The high burden of HCV and associated CLD among inmates should be weighed when determining future resource allocation for HCV treatment and CLD management programs in correctional settings. Comparison of Inmates Hospitalized Once by Inmates Readmitted by Demographics and HCV and CLD ICD9 Codes Disclosures: Arthur Y. Kim – Consulting: Abbvie Pharmaceuticals, Gilead Pharmaceuticals; Grant/Research Support: Bristol-Myers Squibb, Gilead Pharmaceuticals Barbara H. McGovern – Employment: AbbVie The following people have
nothing to disclose: Alysse G. Wurcel, Michaela Superson, Kathryn Noonan INTRODUCTION: In 2012, the CDC released new guidelines recommending selleck compound one time testing for HCV for all persons born from 1945 to 1965. Testing this birth cohort is thought to identify three fourths of all individuals with HCV. Our study proposes that the 1945-1965 birth cohort may not work equally in different ethnicities and gender. METHODS: This retrospective study included all patients who were seen at our center for evaluation of HCV between February 2013 and April 2014. Patients’ charts were reviewed and demographic data were collected with emphasis on ACP-196 order year of birth, race, and sex. Different birth cohorts were constructed and compared in regard to the number of patients in each cohort. The effects of race and sex were studied.RESULTS: The total number of patients
reviewed was 1011 patients (51% males). The mean age was 51.6 (SD=11.4). Most patients were white (63%). African Americans constitute 31% and Hispanics constitute 1 %. Applying CDC guidelines (testing those born from 1945 to 1965) would capture 65% of HCV patients. Broadening
those tested by an additional 5 years (1945 to 1970) would increase the percent of patients detected to 75% (in the total sample) and 90% in African Americans and Hispanics. Furthermore, using the CDC criteria for white and for the female population only captured approximately 50% of the HCV positive patients. Expanding the testing by 5 years (1945-1970) increased the yield to 68% (Figure 1). CONCLUSION: In our study, applying CDC guidelines captured only 65% of the general population and 50% of whites and females. medchemexpress Adding 5 years to the birth cohort (1945-1970) would capture 75% of HCV patients in the general population, and 68% in whites and females. Distribution of HCV patients by race and birth year. Disclosures: Mohamed G. Shoreibah – Advisory Committees or Review Panels: Gilead ; Stock Shareholder: Gilead The following people have nothing to disclose: Cynthia E. Jordan, Shabnam Sarker, Mary L. McCain, Arvind Tripathi, Omar Massoud ELF is a non-invasive serological panel which comprises hyaluronic acid (HA), tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and aminoterminal propeptide of procollagen type III (PIIINP).